Epistem's Biomarker Division Receives GCLP Accreditation | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK biotech Epistem said today its Biomarker Division has received Good Clinical Laboratory Practice accreditation status.

The company said in a statement that the accreditation allows it to support later phases of drug development, and that all studies will be conducted to meet GCLP standards established by the British Association of Research Quality Assurance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.